What are the diagnostic criteria for amyotrophic lateral sclerosis (ALS)?

Diagnostic Criteria for ALS

The diagnosis of ALS requires clinical evidence of both upper motor neuron (UMN) and lower motor neuron (LMN) degeneration, with electromyography (EMG) and nerve conduction studies serving as key diagnostic tests to confirm LMN involvement, while imaging is primarily used to exclude alternative diagnoses rather than confirm ALS. 1

Core Clinical Features Required for Diagnosis

The fundamental diagnostic approach centers on identifying:

• Upper Motor Neuron Signs: Hypertonicity, hyperreflexia, spasticity, and pyramidal tract signs
• Lower Motor Neuron Signs: Muscle fasciculations, weakness, atrophy, and EMG evidence of denervation (fibrillation potentials)

Electromyography is considered equivalent to clinical examination for identifying LMN signs, representing a major advancement in diagnostic criteria 2. This means EMG findings of fibrillation potentials carry the same diagnostic weight as clinical observation of muscle atrophy or weakness.

Evolution of Diagnostic Criteria

Gold Coast Criteria (2019-2024) - Most Current

The Gold Coast criteria represent the most recent consensus and demonstrate superior sensitivity compared to previous criteria, particularly for atypical phenotypes 3, 4. These simplified criteria:

• Merge multiple diagnostic certainty levels into a more practical framework
• Show up to 50% increased potential enrollment in clinical trials
• Maintain diagnostic accuracy across disease duration, functional status, and site of onset
• Better differentiate atypical phenotypes like primary lateral sclerosis from typical ALS

Awaji Criteria (2006)

The Awaji criteria improved upon earlier frameworks by:

• Elevating EMG findings to equal status with clinical examination
• Restoring fasciculation potentials to diagnostic prominence
• Improving sensitivity without compromising specificity 2, 5

Revised El Escorial Criteria

Earlier criteria required LMN involvement in at least two limbs and UMN involvement in at least one region (bulbar, cervical, or lumbosacral), with EMG evidence of fibrillation potentials mandatory for LMN confirmation 6.

Diagnostic Timeline and Challenges

The average time from symptom onset to diagnosis is 9.7-12 months, highlighting the difficulty in early detection 1, 6. This delay stems from:

• Variable clinical presentations (bulbar-onset, spinal-onset, or respiratory-onset variants)
• Absence of definitive biomarkers
• Need to exclude mimicking conditions

Role of Diagnostic Testing

Electrophysiology (Primary Diagnostic Tool)

EMG and nerve conduction velocity studies are the key tests for diagnosing ALS 1. These studies:

• Confirm LMN degeneration through fibrillation potentials
• Document widespread denervation
• Help exclude alternative neuromuscular disorders

Neuroimaging (Exclusionary Role)

MRI of the brain and spine without IV contrast is usually appropriate for initial imaging, but serves primarily to exclude other conditions rather than confirm ALS 1.

Brain MRI findings (supportive but not diagnostic):

• Abnormal T2/FLAIR signal along corticospinal tracts (most frequent in posterior limb of internal capsule and cerebral peduncles)
• Hypointensity on T2*/susceptibility-weighted imaging in the precentral gyrus (highly sensitive and specific when present) 1

Spine MRI findings (often absent early):

• "Snake eyes" appearance: abnormal T2/STIR signal in anterior horns
• Reflects lower motor neuron disease but not specific for ALS
• May only appear later in disease course 1

CT imaging is not useful due to limited soft-tissue characterization 1.

Critical Exclusionary Requirement

There must be no better explanation for the clinical and paraclinical abnormalities than ALS for a secure diagnosis 1. This requires excluding:

• Structural lesions (tumors, cervical myelopathy)
• Multifocal motor neuropathy
• Kennedy's disease
• Myasthenia gravis
• Cervical spondylotic myelopathy
• Other motor neuron disorders

Common Diagnostic Pitfalls

1. Overreliance on imaging: Remember that normal MRI does not exclude ALS, and imaging abnormalities are often absent early in disease
2. Waiting for "definite" criteria: The Gold Coast criteria enable earlier diagnosis without requiring progression to multiple body regions
3. Ignoring EMG equivalence: Electrophysiological evidence of LMN involvement carries equal weight to clinical findings
4. Missing atypical presentations: Up to 50% of ALS cases may overlap with frontotemporal dementia, requiring cognitive assessment 7

Practical Diagnostic Algorithm

1. Identify clinical UMN and LMN signs in the same or different body regions
2. Perform EMG/nerve conduction studies to confirm and quantify LMN involvement (fibrillation potentials are diagnostic)
3. Obtain MRI brain and spine without contrast to exclude structural mimics
4. Apply Gold Coast criteria for simplified, sensitive diagnosis
5. Consider genetic testing in familial cases or young-onset disease (C9orf72, SOD1, TARDBP, FUS mutations) 7
6. Assess for cognitive involvement given 50% overlap with frontotemporal dementia 7

The diagnosis can be established earlier using modern criteria, facilitating prompt initiation of disease-modifying therapies and multidisciplinary care, which directly impacts survival and quality of life 3, 4, 8.